{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:13:47Z","timestamp":1790741627511,"version":"4.1.0"},"publisher-location":"Cham","reference-count":124,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319717784","type":"print"},{"value":"9783319717791","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-71779-1_2","type":"book-chapter","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T09:51:01Z","timestamp":1518169861000},"page":"29-57","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Genetic Rodent Models of Huntington Disease"],"prefix":"10.1007","author":[{"given":"J.","family":"Stricker-Shaver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Novati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Yu-Taeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. P.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,10]]},"reference":[{"key":"2_CR1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"2_CR2","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrn3570","volume":"14","author":"MA Pouladi","year":"2013","unstructured":"Pouladi MA, Morton AJ, Hayden MR (2013) Choosing an animal model for the study of Huntington\u2019s disease. Nat Rev Neurosci 14:708\u2013721","journal-title":"Nat Rev Neurosci"},{"key":"2_CR3","first-page":"2179","volume":"9","author":"R Chang","year":"2015","unstructured":"Chang R, Liu X, Li S, Li XJ (2015) Transgenic animal models for study of the pathogenesis of Huntington\u2019s disease and therapy. Drug Des Devel Ther 9:2179\u20132188","journal-title":"Drug Des Devel Ther"},{"key":"2_CR4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","volume":"69","author":"ZR Crook","year":"2011","unstructured":"Crook ZR, Housman D (2011) Huntington\u2019s disease: can mice lead the way to treatment? Neuron 69:423\u2013435","journal-title":"Neuron"},{"key":"2_CR5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1602\/neurorx.2.3.447","volume":"2","author":"JY Li","year":"2005","unstructured":"Li JY, Popovic N, Brundin P (2005) The use of the R6 transgenic mouse models of Huntington\u2019s disease in attempts to develop novel therapeutic strategies. NeuroRx 2:447\u2013464","journal-title":"NeuroRx"},{"key":"2_CR6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s12035-012-8316-3","volume":"46","author":"PM Switonski","year":"2012","unstructured":"Switonski PM, Szlachcic WJ, Gabka A, Krzyzosiak WJ, Figiel M (2012) Mouse models of polyglutamine diseases in therapeutic approaches: review and data table Part II. Mol Neurobiol 46:430\u2013466","journal-title":"Mol Neurobiol"},{"key":"2_CR7","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1093\/hmg\/ddq285","volume":"19","author":"MY Heng","year":"2010","unstructured":"Heng MY, Duong DK, Albin RL, Tallaksen-Greene SJ, Hunter JM, Lesort MJ, Osmand A, Paulson HL, Detloff PJ (2010) Early autophagic response in a novel knock-in model of Huntington disease. Hum Mol Genet 19:3702\u20133720","journal-title":"Hum Mol Genet"},{"key":"2_CR8","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nm.2224","volume":"16","author":"M Jucker","year":"2010","unstructured":"Jucker M (2010) The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nat Med 16:1210\u20131214","journal-title":"Nat Med"},{"key":"2_CR9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"key":"2_CR10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537\u2013548","journal-title":"Cell"},{"key":"2_CR11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ng0297-197","volume":"15","author":"L Mangiarini","year":"1997","unstructured":"Mangiarini L, Sathasivam K, Mahal A, Mott R, Seller M, Bates GP (1997) Instability of highly expanded CAG repeats in mice transgenic for the Huntington\u2019s disease mutation. Nat Genet 15:197\u2013200","journal-title":"Nat Genet"},{"key":"2_CR12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","volume":"8","author":"G Schilling","year":"1999","unstructured":"Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, Kotzuk JA, Slunt HH, Ratovitski T, Cooper JK, Jenkins NA, Copeland NG, Price DL, Ross CA, Borchelt DR (1999) Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet 8:397\u2013407","journal-title":"Hum Mol Genet"},{"key":"2_CR13","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","volume":"125","author":"RK Graham","year":"2006","unstructured":"Graham RK, Deng Y, Slow EJ, Haigh B, Bissada N, Lu G, Pearson J, Shehadeh J, Bertram L, Murphy Z, Warby SC, Doty CN, Roy S, Wellington CL, Leavitt BR, Raymond LA, Nicholson DW, Hayden MR (2006) Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 125:1179\u20131191","journal-title":"Cell"},{"key":"2_CR14","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/hmg\/ddr176","volume":"20","author":"AT Tebbenkamp","year":"2011","unstructured":"Tebbenkamp AT, Green C, Xu G, Denovan-Wright EM, Rising AC, Fromholt SE, Brown HH, Swing D, Mandel RJ, Tessarollo L, Borchelt DR (2011) Transgenic mice expressing caspase-6-derived N-terminal fragments of mutant huntingtin develop neurologic abnormalities with predominant cytoplasmic inclusion pathology composed largely of a smaller proteolytic derivative. Hum Mol Genet 20:2770\u20132782","journal-title":"Hum Mol Genet"},{"key":"2_CR15","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","volume":"19","author":"RJ Carter","year":"1999","unstructured":"Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation. J Neurosci 19:3248\u20133257","journal-title":"J Neurosci"},{"key":"2_CR16","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cne.20680","volume":"490","author":"EC Stack","year":"2005","unstructured":"Stack EC, Kubilus JK, Smith K, Cormier K, Del Signore SJ, Guelin E, Ryu H, Hersch SM, Ferrante RJ (2005) Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington\u2019s disease transgenic mice. J Comp Neurol 490:354\u2013370","journal-title":"J Comp Neurol"},{"key":"2_CR17","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1098\/rstb.1999.0447","volume":"354","author":"K Sathasivam","year":"1999","unstructured":"Sathasivam K, Hobbs C, Mangiarini L, Mahal A, Turmaine M, Doherty P, Davies SW, Bates GP (1999) Transgenic models of Huntington\u2019s disease. Philos Trans R Soc Lond B Biol Sci 354:963\u2013969","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2_CR18","doi-asserted-by":"crossref","first-page":"e75108","DOI":"10.1371\/journal.pone.0075108","volume":"8","author":"D Young","year":"2013","unstructured":"Young D, Mayer F, Vidotto N, Schweizer T, Berth R, Abramowski D, Shimshek DR, van der Putten PH, Schmid P (2013) Mutant huntingtin gene-dose impacts on aggregate deposition, DARPP32 expression and neuroinflammation in HdhQ150 mice. PLoS ONE 8:e75108","journal-title":"PLoS ONE"},{"key":"2_CR19","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/hmg\/ddh175","volume":"13","author":"G Schilling","year":"2004","unstructured":"Schilling G, Savonenko AV, Klevytska A, Morton JL, Tucker SM, Poirier M, Gale A, Chan N, Gonzales V, Slunt HH, Coonfield ML, Jenkins NA, Copeland NG, Ross CA, Borchelt DR (2004) Nuclear-targeting of mutant huntingtin fragments produces Huntington\u2019s disease-like phenotypes in transgenic mice. Hum Mol Genet 13:1599\u20131610","journal-title":"Hum Mol Genet"},{"key":"2_CR20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1523\/JNEUROSCI.1305-11.2012","volume":"32","author":"E Waldron-Roby","year":"2012","unstructured":"Waldron-Roby E, Ratovitski T, Wang X, Jiang M, Watkin E, Arbez N, Graham RK, Hayden MR, Hou Z, Mori S, Swing D, Pletnikov M, Duan W, Tessarollo L, Ross CA (2012) Transgenic mouse model expressing the caspase 6 fragment of mutant huntingtin. J Neurosci 32:183\u2013193","journal-title":"J Neurosci"},{"key":"2_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2005.01.024","volume":"20","author":"MA Hickey","year":"2005","unstructured":"Hickey MA, Gallant K, Gross GG, Levine MS, Chesselet MF (2005) Early behavioral deficits in R6\/2 mice suitable for use in preclinical drug testing. Neurobiol Dis 20:1\u201311","journal-title":"Neurobiol Dis"},{"key":"2_CR22","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11910-011-0215-x","volume":"11","author":"JS Paulsen","year":"2011","unstructured":"Paulsen JS (2011) Cognitive impairment in Huntington disease: diagnosis and treatment. Curr Neurol Neurosci Rep 11:474\u2013483","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2_CR23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1076\/jcen.24.2.133.998","volume":"24","author":"JS Snowden","year":"2002","unstructured":"Snowden JS, Craufurd D, Thompson J, Neary D (2002) Psychomotor, executive, and memory function in preclinical Huntington\u2019s disease. J Clin Exp Neuropsychol 24:133\u2013145","journal-title":"J Clin Exp Neuropsychol"},{"key":"2_CR24","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","volume":"19","author":"LA Lione","year":"1999","unstructured":"Lione LA, Carter RJ, Hunt MJ, Bates GP, Morton AJ, Dunnett SB (1999) Selective discrimination learning impairments in mice expressing the human Huntington\u2019s disease mutation. J Neurosci 19:10428\u201310437","journal-title":"J Neurosci"},{"key":"2_CR25","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1037\/0735-7044.117.6.1233","volume":"117","author":"VJ Bolivar","year":"2003","unstructured":"Bolivar VJ, Manley K, Messer A (2003) Exploratory activity and fear conditioning abnormalities develop early in R6\/2 Huntington\u2019s disease transgenic mice. Behav Neurosci 117:1233\u20131242","journal-title":"Behav Neurosci"},{"key":"2_CR26","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nmeth1006-767","volume":"3","author":"AJ Morton","year":"2006","unstructured":"Morton AJ, Skillings E, Bussey TJ, Saksida LM (2006) Measuring cognitive deficits in disabled mice using an automated interactive touchscreen system. Nat Methods 3:767","journal-title":"Nat Methods"},{"key":"2_CR27","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/ilar.48.4.356","volume":"48","author":"S Ramaswamy","year":"2007","unstructured":"Ramaswamy S, McBride JL, Kordower JH (2007) Animal models of Huntington\u2019s disease. ILAR J 48:356\u2013373","journal-title":"ILAR J"},{"key":"2_CR28","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/npp.2011.128","volume":"36","author":"CT Chiu","year":"2011","unstructured":"Chiu CT, Liu G, Leeds P, Chuang DM (2011) Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington\u2019s disease. Neuropsychopharmacology 36:2406\u20132421","journal-title":"Neuropsychopharmacology"},{"key":"2_CR29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2217\/nmt.11.45","volume":"1","author":"EA Epping","year":"2011","unstructured":"Epping EA, Paulsen JS (2011) Depression in the early stages of Huntington disease. Neurodegener Dis Manag 1:407\u2013414","journal-title":"Neurodegener Dis Manag"},{"key":"2_CR30","first-page":"135","volume":"8","author":"P Pla","year":"2014","unstructured":"Pla P, Orvoen S, Saudou F, David DJ, Humbert S (2014) Mood disorders in Huntington\u2019s disease: from behavior to cellular and molecular mechanisms. Front Behav Neurosci 8:135","journal-title":"Front Behav Neurosci"},{"key":"2_CR31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1097-2765(02)00602-0","volume":"10","author":"A Lunkes","year":"2002","unstructured":"Lunkes A, Lindenberg KS, Ben-Haiem L, Weber C, Devys D, Landwehrmeyer GB, Mandel JL, Trottier Y (2002) Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. Mol Cell 10:259\u2013269","journal-title":"Mol Cell"},{"key":"2_CR32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/nen.0b013e318040b2c8","volume":"66","author":"G Schilling","year":"2007","unstructured":"Schilling G, Klevytska A, Tebbenkamp AT, Juenemann K, Cooper J, Gonzales V, Slunt H, Poirer M, Ross CA, Borchelt DR (2007) Characterization of huntingtin pathologic fragments in human Huntington disease, transgenic mice, and cell models. J Neuropathol Exp Neurol 66:313\u2013320","journal-title":"J Neuropathol Exp Neurol"},{"key":"2_CR33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"key":"2_CR34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1006\/nbdi.2001.0385","volume":"8","author":"G Schilling","year":"2001","unstructured":"Schilling G, Jinnah HA, Gonzales V, Coonfield ML, Kim Y, Wood JD, Price DL, Li XJ, Jenkins N, Copeland N, Moran T, Ross CA, Borchelt DR (2001) Distinct behavioral and neuropathological abnormalities in transgenic mouse models of HD and DRPLA. Neurobiol Dis 8:405\u2013418","journal-title":"Neurobiol Dis"},{"key":"2_CR35","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, Oh R, Bissada N, Hossain SM, Yang YZ, Li XJ, Simpson EM, Gutekunst CA, Leavitt BR, Hayden MR (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12:1555\u20131567","journal-title":"Hum Mol Genet"},{"key":"2_CR36","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","volume":"28","author":"M Gray","year":"2008","unstructured":"Gray M, Shirasaki DI, Cepeda C, Andre VM, Wilburn B, Lu XH, Tao J, Yamazaki I, Li SH, Sun YE, Li XJ, Levine MS, Yang XW (2008) Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci 28:6182\u20136195","journal-title":"J Neurosci"},{"key":"2_CR37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","volume":"23","author":"JG Hodgson","year":"1999","unstructured":"Hodgson JG, Agopyan N, Gutekunst CA, Leavitt BR, LePiane F, Singaraja R, Smith DJ, Bissada N, McCutcheon K, Nasir J, Jamot L, Li XJ, Stevens ME, Rosemond E, Roder JC, Phillips AG, Rubin EM, Hersch SM, Hayden MR (1999) A YAC mouse model for Huntington\u2019s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23:181\u2013192","journal-title":"Neuron"},{"key":"2_CR38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JHD-140116","volume":"4","author":"M Wegrzynowicz","year":"2015","unstructured":"Wegrzynowicz M, Bichell TJ, Soares BD, Loth MK, McGlothan JS, Mori S, Alikhan FS, Hua K, Coughlin JM, Holt HK, Jetter CS, Pomper MG, Osmand AP, Guilarte TR, Bowman AB (2015) Novel BAC mouse model of Huntington\u2019s disease with 225 CAG repeats exhibits an early widespread and stable degenerative phenotype. J Huntingtons Dis 4:17\u201336","journal-title":"J Huntingtons Dis"},{"key":"2_CR39","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/hmg\/ddi147","volume":"14","author":"JM Raamsdonk Van","year":"2005","unstructured":"Van Raamsdonk JM, Pearson J, Rogers DA, Bissada N, Vogl AW, Hayden MR, Leavitt BR (2005) Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease. Hum Mol Genet 14:1379\u20131392","journal-title":"Hum Mol Genet"},{"issue":"19","key":"2_CR40","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000334276.09729.0e","volume":"71","author":"NA Aziz","year":"2008","unstructured":"Aziz NA, Van Der Burg JM, Landwehrmeyer GB, Brundin P, Stijnen T, Group ES, Roos RAC (2008) Weight loss in Huntington disease increases with higher CAG repeat number. Neurology 71(19):1506\u20131513","journal-title":"Neurology"},{"key":"2_CR41","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/dds037","volume":"21","author":"MA Pouladi","year":"2012","unstructured":"Pouladi MA, Stanek LM, Xie Y, Franciosi S, Southwell AL, Deng Y, Butland S, Zhang W, Cheng SH, Shihabuddin LS, Hayden MR (2012) Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice. Hum Mol Genet 21:2219\u20132232","journal-title":"Hum Mol Genet"},{"key":"2_CR42","doi-asserted-by":"crossref","first-page":"e107691","DOI":"10.1371\/journal.pone.0107691","volume":"9","author":"B Baldo","year":"2014","unstructured":"Baldo B, Cheong RY, Petersen A (2014) Effects of deletion of mutant huntingtin in steroidogenic factor 1 neurons on the psychiatric and metabolic phenotype in the BACHD mouse model of Huntington disease. PLoS ONE 9:e107691","journal-title":"PLoS ONE"},{"key":"2_CR43","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1093\/hmg\/ddl072","volume":"15","author":"JM Raamsdonk Van","year":"2006","unstructured":"Van Raamsdonk JM, Gibson WT, Pearson J, Murphy Z, Lu G, Leavitt BR, Hayden MR (2006) Body weight is modulated by levels of full-length huntingtin. Hum Mol Genet 15:1513\u20131523","journal-title":"Hum Mol Genet"},{"key":"2_CR44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.nbd.2015.01.002","volume":"76","author":"AL Southwell","year":"2015","unstructured":"Southwell AL, Franciosi S, Villanueva EB, Xie Y, Winter LA, Veeraraghavan J, Jonason A, Felczak B, Zhang W, Kovalik V, Waltl S, Hall G, Pouladi MA, Smith ES, Bowers WJ, Zauderer M, Hayden MR (2015) Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease. Neurobiol Dis 76:46\u201356","journal-title":"Neurobiol Dis"},{"key":"2_CR45","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.nbd.2007.01.006","volume":"26","author":"JM Raamsdonk Van","year":"2007","unstructured":"Van Raamsdonk JM, Murphy Z, Selva DM, Hamidizadeh R, Pearson J, Petersen A, Bjorkqvist M, Muir C, Mackenzie IR, Hammond GL, Vogl AW, Hayden MR, Leavitt BR (2007) Testicular degeneration in Huntington disease. Neurobiol Dis 26:512\u2013520","journal-title":"Neurobiol Dis"},{"key":"2_CR46","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cmet.2011.02.013","volume":"13","author":"S Hult","year":"2011","unstructured":"Hult S, Soylu R, Bjorklund T, Belgardt BF, Mauer J, Bruning JC, Kirik D, Petersen A (2011) Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits. Cell Metab 13:428\u2013439","journal-title":"Cell Metab"},{"key":"2_CR47","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archneur.65.4.476","volume":"65","author":"NM Lalic","year":"2008","unstructured":"Lalic NM, Maric J, Svetel M, Jotic A, Stefanova E, Lalic K, Dragasevic N, Milicic T, Lukic L, Kostic VS (2008) Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion. Arch Neurol 65:476\u2013480","journal-title":"Arch Neurol"},{"key":"2_CR48","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/hmg\/ddq026","volume":"19","author":"MA Pouladi","year":"2010","unstructured":"Pouladi MA, Xie Y, Skotte NH, Ehrnhoefer DE, Graham RK, Kim JE, Bissada N, Yang XW, Paganetti P, Friedlander RM, Leavitt BR, Hayden MR (2010) Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression. Hum Mol Genet 19:1528\u20131538","journal-title":"Hum Mol Genet"},{"key":"2_CR49","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1210\/jc.2008-2543","volume":"94","author":"NA Aziz","year":"2009","unstructured":"Aziz NA, Pijl H, Frolich M, van der Graaf AW, Roelfsema F, Roos RA (2009) Increased hypothalamic-pituitary-adrenal axis activity in Huntington\u2019s disease. J Clin Endocrinol Metab 94:1223\u20131228","journal-title":"J Clin Endocrinol Metab"},{"key":"2_CR50","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.20428","volume":"57","author":"M Markianos","year":"2005","unstructured":"Markianos M, Panas M, Kalfakis N, Vassilopoulos D (2005) Plasma testosterone in male patients with Huntington\u2019s disease: relations to severity of illness and dementia. Ann Neurol 57:520\u2013525","journal-title":"Ann Neurol"},{"key":"2_CR51","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","volume":"35","author":"L Menalled","year":"2009","unstructured":"Menalled L, El-Khodor BF, Patry M, Suarez-Farinas M, Orenstein SJ, Zahasky B, Leahy C, Wheeler V, Yang XW, MacDonald M, Morton AJ, Bates G, Leeds J, Park L, Howland D, Signer E, Tobin A, Brunner D (2009) Systematic behavioral evaluation of Huntington\u2019s disease transgenic and knock-in mouse models. Neurobiol Dis 35:319\u2013336","journal-title":"Neurobiol Dis"},{"key":"2_CR52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1750-1326-6-81","volume":"6","author":"X Chen","year":"2011","unstructured":"Chen X, Wu J, Lvovskaya S, Herndon E, Supnet C, Bezprozvanny I (2011) Dantrolene is neuroprotective in Huntington\u2019s disease transgenic mouse model. Mol Neurodegener 6:81","journal-title":"Mol Neurodegener"},{"key":"2_CR53","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/hmg\/ddw050","volume":"25","author":"S Mantovani","year":"2016","unstructured":"Mantovani S, Gordon R, Li R, Christie DC, Kumar V, Woodruff TM (2016) Motor deficits associated with Huntington\u2019s disease occur in the absence of striatal degeneration in BACHD transgenic mice. Hum Mol Genet 25:1780\u20131791","journal-title":"Hum Mol Genet"},{"key":"2_CR54","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1212\/WNL.0b013e3181ec805b","volume":"75","author":"DG Lichter","year":"2010","unstructured":"Lichter DG, Hershey LA (2010) Before chorea: pre-Huntington mild cognitive impairment. Neurology 75:490\u2013491","journal-title":"Neurology"},{"key":"2_CR55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JHD-120023","volume":"1","author":"A Giralt","year":"2012","unstructured":"Giralt A, Saavedra A, Alberch J, Perez-Navarro E (2012) Cognitive dysfunction in Huntington\u2019s disease: humans, mouse models and molecular mechanisms. J Huntingtons Dis 1:155\u2013173","journal-title":"J Huntingtons Dis"},{"key":"2_CR56","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/bph.12164","volume":"169","author":"JG Doria","year":"2013","unstructured":"Doria JG, Silva FR, de Souza JM, Vieira LB, Carvalho TG, Reis HJ, Pereira GS, Dobransky T, Ribeiro FM (2013) Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington\u2019s disease. Br J Pharmacol 169:909\u2013921","journal-title":"Br J Pharmacol"},{"key":"2_CR57","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","volume":"29","author":"AL Southwell","year":"2009","unstructured":"Southwell AL, Ko J, Patterson PH (2009) Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington\u2019s disease. J Neurosci 29:13589\u201313602","journal-title":"J Neurosci"},{"key":"2_CR58","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","volume":"25","author":"JM Raamsdonk Van","year":"2005","unstructured":"Van Raamsdonk JM, Pearson J, Slow EJ, Hossain SM, Leavitt BR, Hayden MR (2005) Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington\u2019s disease. J Neurosci 25:4169\u20134180","journal-title":"J Neurosci"},{"key":"2_CR59","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bbr.2012.10.039","volume":"238","author":"YS Abada","year":"2013","unstructured":"Abada YS, Schreiber R, Ellenbroek B (2013) Motor, emotional and cognitive deficits in adult BACHD mice: a model for Huntington\u2019s disease. Behav Brain Res 238:243\u2013251","journal-title":"Behav Brain Res"},{"key":"2_CR60","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/hmg\/ddv023","volume":"24","author":"I Aharony","year":"2015","unstructured":"Aharony I, Ehrnhoefer DE, Shruster A, Qiu X, Franciosi S, Hayden MR, Offen D (2015) A Huntingtin-based peptide inhibitor of caspase-6 provides protection from mutant Huntingtin-induced motor and behavioral deficits. Hum Mol Genet 24:2604\u20132614","journal-title":"Hum Mol Genet"},{"key":"2_CR61","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.brainresbull.2010.05.005","volume":"88","author":"S Brooks","year":"2012","unstructured":"Brooks S, Higgs G, Janghra N, Jones L, Dunnett SB (2012) Longitudinal analysis of the behavioural phenotype in YAC128 (C57BL\/6\u00a0J) Huntington\u2019s disease transgenic mice. Brain Res Bull 88:113\u2013120","journal-title":"Brain Res Bull"},{"key":"2_CR62","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.brainresbull.2011.05.010","volume":"88","author":"SP Brooks","year":"2012","unstructured":"Brooks SP, Janghra N, Higgs GV, Bayram-Weston Z, Heuer A, Jones L, Dunnett SB (2012) Selective cognitive impairment in the YAC128 Huntington\u2019s disease mouse. Brain Res Bull 88:121\u2013129","journal-title":"Brain Res Bull"},{"key":"2_CR63","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1093\/hmg\/ddt203","volume":"22","author":"S Hult Lundh","year":"2013","unstructured":"Hult Lundh S, Nilsson N, Soylu R, Kirik D, Petersen A (2013) Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington\u2019s disease. Hum Mol Genet 22:3485\u20133497","journal-title":"Hum Mol Genet"},{"key":"2_CR64","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/brain\/awp006","volume":"132","author":"MA Pouladi","year":"2009","unstructured":"Pouladi MA, Graham RK, Karasinska JM, Xie Y, Santos RD, Petersen A, Hayden MR (2009) Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin. Brain 132:919\u2013932","journal-title":"Brain"},{"key":"2_CR65","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990\u20131993","journal-title":"Science"},{"key":"2_CR66","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.nbd.2011.03.018","volume":"43","author":"JB Carroll","year":"2011","unstructured":"Carroll JB, Lerch JP, Franciosi S, Spreeuw A, Bissada N, Henkelman RM, Hayden MR (2011) Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease. Neurobiol Dis 43:257\u2013265","journal-title":"Neurobiol Dis"},{"key":"2_CR67","first-page":"2621","volume":"25","author":"RT Teo","year":"2016","unstructured":"Teo RT, Hong X, Yu-Taeger L, Huang Y, Tan LJ, Xie Y, To XV, Guo L, Rajendran R, Novati A, Calaminus C, Riess O, Hayden MR, Nguyen HP, Chuang KH, Pouladi MA (2016) Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington disease. Hum Mol Genet 25:2621\u20132632","journal-title":"Hum Mol Genet"},{"key":"2_CR68","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1093\/hmg\/ddv248","volume":"24","author":"RG Gatto","year":"2015","unstructured":"Gatto RG, Chu Y, Ye AQ, Price SD, Tavassoli E, Buenaventura A, Brady ST, Magin RL, Kordower JH, Morfini GA (2015) Analysis of YFP(J16)-R6\/2 reporter mice and postmortem brains reveals early pathology and increased vulnerability of callosal axons in Huntington\u2019s disease. Hum Mol Genet 24:5285\u20135298","journal-title":"Hum Mol Genet"},{"key":"2_CR69","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1093\/hmg\/ddv016","volume":"24","author":"J Jin","year":"2015","unstructured":"Jin J, Peng Q, Hou Z, Jiang M, Wang X, Langseth AJ, Tao M, Barker PB, Mori S, Bergles DE, Ross CA, Detloff PJ, Zhang J, Duan W (2015) Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington\u2019s disease. Hum Mol Genet 24:2508\u20132527","journal-title":"Hum Mol Genet"},{"key":"2_CR70","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/mds.20979","volume":"21","author":"HD Rosas","year":"2006","unstructured":"Rosas HD, Tuch DS, Hevelone ND, Zaleta AK, Vangel M, Hersch SM, Salat DH (2006) Diffusion tensor imaging in presymptomatic and early Huntington\u2019s disease: Selective white matter pathology and its relationship to clinical measures. Mov Disord 21:1317\u20131325","journal-title":"Mov Disord"},{"issue":"34","key":"2_CR71","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1523\/JNEUROSCI.1830-07.2007","volume":"27","author":"M. Y. Heng","year":"2007","unstructured":"Heng MY, Tallaksen-Greene SJ, Detloff PJ, Albin RL (2007) Longitudinal evaluation of the Hdh(CAG)150 knock-in murine model of Huntington\u2019s disease. J Neurosci 27:8989\u20138998","journal-title":"Journal of Neuroscience"},{"key":"2_CR72","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/8.1.115","volume":"8","author":"VC Wheeler","year":"1999","unstructured":"Wheeler VC, Auerbach W, White JK, Srinidhi J, Auerbach A, Ryan A, Duyao MP, Vrbanac V, Weaver M, Gusella JF, Joyner AL, MacDonald ME (1999) Length-dependent gametic CAG repeat instability in the Huntington\u2019s disease knock-in mouse. Hum Mol Genet 8:115\u2013122","journal-title":"Hum Mol Genet"},{"key":"2_CR73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10776","volume":"465","author":"LB Menalled","year":"2003","unstructured":"Menalled LB, Sison JD, Dragatsis I, Zeitlin S, Chesselet MF (2003) Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats. J Comp Neurol 465:11\u201326","journal-title":"J Comp Neurol"},{"key":"2_CR74","doi-asserted-by":"crossref","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","volume":"7","author":"LB Menalled","year":"2012","unstructured":"Menalled LB, Kudwa AE, Miller S, Fitzpatrick J, Watson-Johnson J, Keating N, Ruiz M, Mushlin R, Alosio W, McConnell K, Connor D, Murphy C, Oakeshott S, Kwan M, Beltran J, Ghavami A, Brunner D, Park LC, Ramboz S, Howland D (2012) Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175. PLoS ONE 7:e49838","journal-title":"PLoS ONE"},{"key":"2_CR75","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","volume":"10","author":"CH Lin","year":"2001","unstructured":"Lin CH, Tallaksen-Greene S, Chien WM, Cearley JA, Jackson WS, Crouse AB, Ren S, Li XJ, Albin RL, Detloff PJ (2001) Neurological abnormalities in a knock-in mouse model of Huntington\u2019s disease. Hum Mol Genet 10:137\u2013144","journal-title":"Hum Mol Genet"},{"key":"2_CR76","doi-asserted-by":"crossref","first-page":"e80923","DOI":"10.1371\/journal.pone.0080923","volume":"8","author":"SM Holter","year":"2013","unstructured":"Holter SM et al (2013) A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in Huntington\u2019s disease CAG knock-in mice. PLoS ONE 8:e80923","journal-title":"PLoS ONE"},{"key":"2_CR77","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/hmg\/ddn428","volume":"18","author":"J Phan","year":"2009","unstructured":"Phan J, Hickey MA, Zhang P, Chesselet MF, Reue K (2009) Adipose tissue dysfunction tracks disease progression in two Huntington\u2019s disease mouse models. Hum Mol Genet 18:1006\u20131016","journal-title":"Hum Mol Genet"},{"key":"2_CR78","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","volume":"9","author":"VC Wheeler","year":"2000","unstructured":"Wheeler VC, White JK, Gutekunst CA, Vrbanac V, Weaver M, Li XJ, Li SH, Yi H, Vonsattel JP, Gusella JF, Hersch S, Auerbach W, Joyner AL, MacDonald ME (2000) Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum Mol Genet 9:503\u2013513","journal-title":"Hum Mol Genet"},{"key":"2_CR79","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuroscience.2008.08.041","volume":"157","author":"MA Hickey","year":"2008","unstructured":"Hickey MA, Kosmalska A, Enayati J, Cohen R, Zeitlin S, Levine MS, Chesselet MF (2008) Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington\u2019s disease mice. Neuroscience 157:280\u2013295","journal-title":"Neuroscience"},{"issue":"5","key":"2_CR80","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/brain\/119.5.1633","volume":"119","author":"Andrew D. Lawrence","year":"1996","unstructured":"Lawrence AD, Sahakian BJ, Hodges JR, Rosser AE, Lange KW, Robbins TW (1996) Executive and mnemonic functions in early Huntington\u2019s disease. Brain 119:1633\u20131645","journal-title":"Brain"},{"key":"2_CR81","first-page":"361","volume":"9","author":"PC Curtin","year":"2015","unstructured":"Curtin PC, Farrar AM, Oakeshott S, Sutphen J, Berger J, Mazzella M, Cox K, He D, Alosio W, Park LC, Howland D, Brunner D (2015) Cognitive training at a young age attenuates deficits in the zQ175 mouse model of HD. Front Behav Neurosci 9:361","journal-title":"Front Behav Neurosci"},{"key":"2_CR82","doi-asserted-by":"crossref","first-page":"e50717","DOI":"10.1371\/journal.pone.0050717","volume":"7","author":"T Heikkinen","year":"2012","unstructured":"Heikkinen T, Lehtimaki K, Vartiainen N, Puolivali J, Hendricks SJ, Glaser JR, Bradaia A, Wadel K, Touller C, Kontkanen O, Yrjanheikki JM, Buisson B, Howland D, Beaumont V, Munoz-Sanjuan I, Park LC (2012) Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington\u2019s disease. PLoS ONE 7:e50717","journal-title":"PLoS ONE"},{"key":"2_CR83","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1093\/hmg\/ddu166","volume":"23","author":"GA Smith","year":"2014","unstructured":"Smith GA, Rocha EM, McLean JR, Hayes MA, Izen SC, Isacson O, Hallett PJ (2014) Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington\u2019s disease. Hum Mol Genet 23:4510\u20134527","journal-title":"Hum Mol Genet"},{"key":"2_CR84","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.brainresbull.2010.05.004","volume":"88","author":"S Brooks","year":"2012","unstructured":"Brooks S, Higgs G, Jones L, Dunnett SB (2012) Longitudinal analysis of the behavioural phenotype in Hdh(CAG)150 Huntington\u2019s disease knock-in mice. Brain Res Bull 88:182\u2013188","journal-title":"Brain Res Bull"},{"key":"2_CR85","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2011.11.063","volume":"507","author":"S Orvoen","year":"2012","unstructured":"Orvoen S, Pla P, Gardier AM, Saudou F, David DJ (2012) Huntington\u2019s disease knock-in male mice show specific anxiety-like behaviour and altered neuronal maturation. Neurosci Lett 507:127\u2013132","journal-title":"Neurosci Lett"},{"key":"2_CR86","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbr.2015.05.010","volume":"291","author":"A Ciamei","year":"2015","unstructured":"Ciamei A, Detloff PJ, Morton AJ (2015) Progression of behavioural despair in R6\/2 and Hdh knock-in mouse models recapitulates depression in Huntington\u2019s disease. Behav Brain Res 291:140\u2013146","journal-title":"Behav Brain Res"},{"key":"2_CR87","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/hmg\/11.6.633","volume":"11","author":"VC Wheeler","year":"2002","unstructured":"Wheeler VC, Gutekunst CA, Vrbanac V, Lebel LA, Schilling G, Hersch S, Friedlander RM, Gusella JF, Vonsattel JP, Borchelt DR, MacDonald ME (2002) Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice. Hum Mol Genet 11:633\u2013640","journal-title":"Hum Mol Genet"},{"key":"2_CR88","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.brainresbull.2012.01.012","volume":"87","author":"RP Lerner","year":"2012","unstructured":"Lerner RP, Trejo Martinez Ldel C, Zhu C, Chesselet MF, Hickey MA (2012) Striatal atrophy and dendritic alterations in a knock-in mouse model of Huntington\u2019s disease. Brain Res Bull 87:571\u2013578","journal-title":"Brain Res Bull"},{"key":"2_CR89","doi-asserted-by":"crossref","first-page":"e00036","DOI":"10.1042\/AN20100007","volume":"2","author":"DM Cummings","year":"2010","unstructured":"Cummings DM, Cepeda C, Levine MS (2010) Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington\u2019s disease. ASN Neuro 2:e00036","journal-title":"ASN Neuro"},{"key":"2_CR90","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1523\/JNEUROSCI.23-06-02193.2003","volume":"23","author":"ZX Yu","year":"2003","unstructured":"Yu ZX, Li SH, Evans J, Pillarisetti A, Li H, Li XJ (2003) Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington\u2019s disease. J Neurosci 23:2193\u20132202","journal-title":"J Neurosci"},{"key":"2_CR91","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.chembiol.2011.12.020","volume":"19","author":"B Baldo","year":"2012","unstructured":"Baldo B, Paganetti P, Grueninger S, Marcellin D, Kaltenbach LS, Lo DC, Semmelroth M, Zivanovic A, Abramowski D, Smith D, Lotz GP, Bates GP, Weiss A (2012) TR-FRET-based duplex immunoassay reveals an inverse correlation of soluble and aggregated mutant huntingtin in huntington\u2019s disease. Chem Biol 19:264\u2013275","journal-title":"Chem Biol"},{"key":"2_CR92","doi-asserted-by":"crossref","first-page":"e44457","DOI":"10.1371\/journal.pone.0044457","volume":"7","author":"D Marcellin","year":"2012","unstructured":"Marcellin D, Abramowski D, Young D, Richter J, Weiss A, Marcel A, Maassen J, Kauffmann M, Bibel M, Shimshek DR, Faull RL, Bates GP, Kuhn RR, Van der Putten PH, Schmid P, Lotz GP (2012) Fragments of HdhQ150 mutant huntingtin form a soluble oligomer pool that declines with aggregate deposition upon aging. PLoS ONE 7:e44457","journal-title":"PLoS ONE"},{"key":"2_CR93","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/brain\/awg077","volume":"126","author":"F Squitieri","year":"2003","unstructured":"Squitieri F, Gellera C, Cannella M, Mariotti C, Cislaghi G, Rubinsztein DC, Almqvist EW, Turner D, Bachoud-Levi AC, Simpson SA, Delatycki M, Maglione V, Hayden MR, Donato SD (2003) Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain 126:946\u2013955","journal-title":"Brain"},{"key":"2_CR94","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4161\/auto.6.8.13617","volume":"6","author":"MY Heng","year":"2010","unstructured":"Heng MY, Detloff PJ, Paulson HL, Albin RL (2010) Early alterations of autophagy in Huntington disease-like mice. Autophagy 6:1206\u20131208","journal-title":"Autophagy"},{"key":"2_CR95","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.expneurol.2012.11.015","volume":"240","author":"SE Dougherty","year":"2013","unstructured":"Dougherty SE, Reeves JL, Lesort M, Detloff PJ, Cowell RM (2013) Purkinje cell dysfunction and loss in a knock-in mouse model of Huntington disease. Exp Neurol 240:96\u2013102","journal-title":"Exp Neurol"},{"key":"2_CR96","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s13311-012-0112-2","volume":"9","author":"ME Ehrlich","year":"2012","unstructured":"Ehrlich ME (2012) Huntington\u2019s disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease. Neurotherapeutics 9:270\u2013284","journal-title":"Neurotherapeutics"},{"key":"2_CR97","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","volume":"81","author":"C Zuccato","year":"2007","unstructured":"Zuccato C, Cattaneo E (2007) Role of brain-derived neurotrophic factor in Huntington\u2019s disease. Prog Neurobiol 81:294\u2013330","journal-title":"Prog Neurobiol"},{"key":"2_CR98","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4329\/wjr.v6.i6.301","volume":"6","author":"F Niccolini","year":"2014","unstructured":"Niccolini F, Politis M (2014) Neuroimaging in Huntington\u2019s disease. World J Radiol 6:301\u2013312","journal-title":"World J Radiol"},{"key":"2_CR99","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/hmg\/ddg075","volume":"12","author":"S Horsten von","year":"2003","unstructured":"von Horsten S et al (2003) Transgenic rat model of Huntington\u2019s disease. Hum Mol Genet 12:617\u2013624","journal-title":"Hum Mol Genet"},{"key":"2_CR100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbr.2012.10.048","volume":"239","author":"RD Kirch","year":"2013","unstructured":"Kirch RD, Meyer PT, Geisler S, Braun F, Gehrig S, Langen KJ, von Horsten S, Nikkhah G, Cassel JC, Dobrossy MD (2013) Early deficits in declarative and procedural memory dependent behavioral function in a transgenic rat model of Huntington\u2019s disease. Behav Brain Res 239:15\u201326","journal-title":"Behav Brain Res"},{"key":"2_CR101","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1093\/hmg\/ddl394","volume":"15","author":"HP Nguyen","year":"2006","unstructured":"Nguyen HP, Kobbe P, Rahne H, Worpel T, Jager B, Stephan M, Pabst R, Holzmann C, Riess O, Korr H, Kantor O, Petrasch-Parwez E, Wetzel R, Osmand A, von Horsten S (2006) Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington\u2019s disease. Hum Mol Genet 15:3177\u20133194","journal-title":"Hum Mol Genet"},{"key":"2_CR102","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/cne.21272","volume":"501","author":"E Petrasch-Parwez","year":"2007","unstructured":"Petrasch-Parwez E, Nguyen HP, Lobbecke-Schumacher M, Habbes HW, Wieczorek S, Riess O, Andres KH, Dermietzel R, Von Horsten S (2007) Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease. J Comp Neurol 501:716\u2013730","journal-title":"J Comp Neurol"},{"key":"2_CR103","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.nbd.2005.12.014","volume":"22","author":"O Kantor","year":"2006","unstructured":"Kantor O, Temel Y, Holzmann C, Raber K, Nguyen HP, Cao C, Turkoglu HO, Rutten BP, Visser-Vandewalle V, Steinbusch HW, Blokland A, Korr H, Riess O, von Horsten S, Schmitz C (2006) Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington\u2019s disease transgenic rats. Neurobiol Dis 22:538\u2013547","journal-title":"Neurobiol Dis"},{"key":"2_CR104","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.brainresbull.2006.01.003","volume":"69","author":"C Winkler","year":"2006","unstructured":"Winkler C, Gil JM, Araujo IM, Riess O, Skripuletz T, von Horsten S, Petersen A (2006) Normal sensitivity to excitotoxicity in a transgenic Huntington\u2019s disease rat. Brain Res Bull 69:306\u2013310","journal-title":"Brain Res Bull"},{"key":"2_CR105","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1037\/a0028028","volume":"126","author":"KD Fink","year":"2012","unstructured":"Fink KD, Rossignol J, Crane AT, Davis KK, Bavar AM, Dekorver NW, Lowrance SA, Reilly MP, Sandstrom MI, von Horsten S, Lescaudron L, Dunbar GL (2012) Early cognitive dysfunction in the HD 51 CAG transgenic rat model of Huntington\u2019s disease. Behav Neurosci 126:479\u2013487","journal-title":"Behav Neurosci"},{"key":"2_CR106","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.expneurol.2011.03.014","volume":"229","author":"C Casteels","year":"2011","unstructured":"Casteels C, Vandeputte C, Rangarajan JR, Dresselaers T, Riess O, Bormans G, Maes F, Himmelreich U, Nguyen H, Van Laere K (2011) Metabolic and type 1 cannabinoid receptor imaging of a transgenic rat model in the early phase of Huntington disease. Exp Neurol 229:440\u2013449","journal-title":"Exp Neurol"},{"key":"2_CR107","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/NEN.0b013e3181e4f733","volume":"69","author":"M Kandasamy","year":"2010","unstructured":"Kandasamy M, Couillard-Despres S, Raber KA, Stephan M, Lehner B, Winner B, Kohl Z, Rivera FJ, Nguyen HP, Riess O, Bogdahn U, Winkler J, von Horsten S, Aigner L (2010) Stem cell quiescence in the hippocampal neurogenic niche is associated with elevated transforming growth factor-beta signaling in an animal model of Huntington disease. J Neuropathol Exp Neurol 69:717\u2013728","journal-title":"J Neuropathol Exp Neurol"},{"key":"2_CR108","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bbr.2006.02.028","volume":"170","author":"C Cao","year":"2006","unstructured":"Cao C, Temel Y, Blokland A, Ozen H, Steinbusch HW, Vlamings R, Nguyen HP, von Horsten S, Schmitz C, Visser-Vandewalle V (2006) Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington\u2019s disease transgenic ratmodel. Behav Brain Res 170:257\u2013261","journal-title":"Behav Brain Res"},{"key":"2_CR109","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jneumeth.2014.06.017","volume":"234","author":"YK Urbach","year":"2014","unstructured":"Urbach YK, Raber KA, Canneva F, Plank AC, Andreasson T, Ponten H, Kullingsjo J, Nguyen HP, Riess O, von Horsten S (2014) Automated phenotyping and advanced data mining exemplified in rats transgenic for Huntington\u2019s disease. J Neurosci Methods 234:38\u201353","journal-title":"J Neurosci Methods"},{"key":"2_CR110","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbr.2011.11.009","volume":"227","author":"DH Zeef","year":"2012","unstructured":"Zeef DH, van Goethem NP, Vlamings R, Schaper F, Jahanshahi A, Hescham S, von Horsten S, Prickaerts J, Temel Y (2012) Memory deficits in the transgenic rat model of Huntington\u2019s disease. Behav Brain Res 227:194\u2013198","journal-title":"Behav Brain Res"},{"key":"2_CR111","doi-asserted-by":"crossref","first-page":"15426","DOI":"10.1523\/JNEUROSCI.1148-12.2012","volume":"32","author":"L Yu-Taeger","year":"2012","unstructured":"Yu-Taeger L, Petrasch-Parwez E, Osmand AP, Redensek A, Metzger S, Clemens LE, Park L, Howland D, Calaminus C, Gu X, Pichler B, Yang XW, Riess O, Nguyen HP (2012) A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease. J Neurosci 32:15426\u201315438","journal-title":"J Neurosci"},{"key":"2_CR112","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nlm.2015.10.003","volume":"125","author":"N Adjeroud","year":"2015","unstructured":"Adjeroud N, Yague S, Yu-Taeger L, Bozon B, Leblanc-Veyrac P, Riess O, Allain P, Nguyen HP, Doyere V, El Massioui N (2015) Reduced impact of emotion on choice behavior in presymptomatic BACHD rats, a transgenic rodent model for Huntington Disease. Neurobiol Learn Mem 125:249\u2013257","journal-title":"Neurobiol Learn Mem"},{"key":"2_CR113","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1093\/brain\/awv290","volume":"138","author":"LE Clemens","year":"2015","unstructured":"Clemens LE, Weber JJ, Wlodkowski TT, Yu-Taeger L, Michaud M, Calaminus C, Eckert SH, Gaca J, Weiss A, Magg JC, Jansson EK, Eckert GP, Pichler BJ, Bordet T, Pruss RM, Riess O, Nguyen HP (2015) Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat. Brain 138:3632\u20133653","journal-title":"Brain"},{"key":"2_CR114","doi-asserted-by":"crossref","first-page":"e0169051","DOI":"10.1371\/journal.pone.0169051","volume":"12","author":"EK Clemensson","year":"2017","unstructured":"Clemensson EK, Clemensson LE, Riess O, Nguyen HP (2017) The BACHD Rat model of huntington disease shows signs of fronto-striatal dysfunction in two operant conditioning tests of short-term memory. PLoS ONE 12:e0169051","journal-title":"PLoS ONE"},{"key":"2_CR115","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnbeh.2016.00204","volume":"10","author":"N Massioui El","year":"2016","unstructured":"El Massioui N, Lamirault C, Yague S, Adjeroud N, Garces D, Maillard A, Tallot L, Yu-Taeger L, Riess O, Allain P, Nguyen HP, von Horsten S, Doyere V (2016) Impaired Decision making and loss of inhibitory-control in a rat model of Huntington disease. Front Behav Neurosci 10:204","journal-title":"Front Behav Neurosci"},{"key":"2_CR116","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuropharm.2017.05.032","volume":"123","author":"C Lamirault","year":"2017","unstructured":"Lamirault C, Yu-Taeger L, Doyere V, Riess O, Nguyen HP, El Massioui N (2017) Altered reactivity of central amygdala to GABAAR antagonist in the BACHD rat model of Huntington disease. Neuropharmacology 123:136\u2013147","journal-title":"Neuropharmacology"},{"key":"2_CR117","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbr.2015.11.007","volume":"299","author":"G Manfre","year":"2016","unstructured":"Manfre G, Doyere V, Bossi S, Riess O, Nguyen HP, El Massioui N (2016) Impulsivity trait in the early symptomatic BACHD transgenic rat model of Huntington disease. Behav Brain Res 299:6\u201310","journal-title":"Behav Brain Res"},{"key":"2_CR118","doi-asserted-by":"crossref","first-page":"e1153778","DOI":"10.1080\/21675511.2016.1153778","volume":"4","author":"JJ Weber","year":"2016","unstructured":"Weber JJ, Ortiz Rios MM, Riess O, Clemens LE, Nguyen HP (2016) The calpain-suppressing effects of olesoxime in Huntington\u2019s disease. Rare Dis 4:e1153778","journal-title":"Rare Dis"},{"key":"2_CR119","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuropharm.2017.01.029","volume":"117","author":"L Yu-Taeger","year":"2017","unstructured":"Yu-Taeger L, Bonin M, Stricker-Shaver J, Riess O, Nguyen HH (2017) Dysregulation of gene expression in the striatum of BACHD rats expressing full-length mutant huntingtin and associated abnormalities on molecular and protein levels. Neuropharmacology 117:260\u2013272","journal-title":"Neuropharmacology"},{"key":"2_CR120","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.expneurol.2014.10.001","volume":"263","author":"D Nagy","year":"2015","unstructured":"Nagy D, Tingley FD 3rd, Stoiljkovic M, Hajos M (2015) Application of neurophysiological biomarkers for Huntington\u2019s disease: evaluating a phosphodiesterase 9A inhibitor. Exp Neurol 263:122\u2013131","journal-title":"Exp Neurol"},{"key":"2_CR121","doi-asserted-by":"crossref","first-page":"e68584","DOI":"10.1371\/journal.pone.0068584","volume":"8","author":"YS Abada","year":"2013","unstructured":"Abada YS, Nguyen HP, Schreiber R, Ellenbroek B (2013) Assessment of motor function, sensory motor gating and recognition memory in a novel BACHD transgenic rat model for huntington disease. PLoS ONE 8:e68584","journal-title":"PLoS ONE"},{"key":"2_CR122","doi-asserted-by":"crossref","first-page":"e71633","DOI":"10.1371\/journal.pone.0071633","volume":"8","author":"YS Abada","year":"2013","unstructured":"Abada YS, Nguyen HP, Ellenbroek B, Schreiber R (2013) Reversal learning and associative memory impairments in a BACHD rat model for Huntington disease. PLoS ONE 8:e71633","journal-title":"PLoS ONE"},{"key":"2_CR123","doi-asserted-by":"crossref","first-page":"e105662","DOI":"10.1371\/journal.pone.0105662","volume":"9","author":"EK Jansson","year":"2014","unstructured":"Jansson EK, Clemens LE, Riess O, Nguyen HP (2014) Reduced motivation in the BACHD rat model of Huntington disease is dependent on the choice of food deprivation strategy. PLoS ONE 9:e105662","journal-title":"PLoS ONE"},{"key":"2_CR124","doi-asserted-by":"crossref","first-page":"e81528","DOI":"10.1371\/journal.pone.0081528","volume":"8","author":"C Gouarne","year":"2013","unstructured":"Gouarne C, Tardif G, Tracz J, Latyszenok V, Michaud M, Clemens LE, Yu-Taeger L, Nguyen HP, Bordet T, Pruss RM (2013) Early deficits in glycolysis are specific to striatal neurons from a rat model of huntington disease. PLoS ONE 8:e81528","journal-title":"PLoS ONE"}],"container-title":["Advances in Experimental Medicine and Biology","Polyglutamine Disorders"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-71779-1_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T23:59:08Z","timestamp":1603843148000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-71779-1_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319717784","9783319717791"],"references-count":124,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-71779-1_2","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}